CML-627 Concomitant Acid-Reducing Agents With TKI Increases Time to Achieve Remission in Patients With CML: A Real-World Analysis of a US Claims Database

Autor: Russo, Pierantonio, Liljebris, Charlotta, Nathan, Ramaa, Sicilia, Michael, Moore, Alex, Prasad, Sudarshan, Andersson, Per
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S379-S379
Databáze: ScienceDirect